Leap Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Cypherpunk Technologies

14/08/2023 14:32

* Leap Therapeutics Inc  LPTX.OQ  reported a quarterly
adjusted
loss of 91 cents​​ per share for the quarter ended in June. The
mean expectation of five analysts for the quarter was for a loss
of 90 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Leap Therapeutics Inc's reported EPS for the quarter was a
loss
of 91 cents​.
    * The mean earnings estimate of analysts had fallen by
about 35.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Leap Therapeutics Inc shares had fallen by 24.6% this
quarter and lost 47.6% so far this year.
    * The company reported a quarterly loss of $13.39 million.
    * Wall Street's median 12-month price target for Leap
Therapeutics
Inc is $25.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.90          -0.91          Missed
 Mar. 31 2023      -0.98          -3.20          Missed
 Dec. 31 2022      -1.10          -1.00          Beat
 Sep. 30 2022      -1.20          -1.30          Missed